GlassScriptPhysician profile
Devin A Wells
NPI 1568881530
$2,407.96
in general payments reported to CMS, 2019-2025
31 companies · $650 in 2025
The $650 reported for 2025 was more than what 82% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $183 · 2020: $78.41 · 2021: $98.51 · 2022: $131 · 2023: $497 · 2024: $770 · 2025: $650.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,917.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,917.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $461.42 | 2020-2025 | Opsumit, Uptravi, Opsynvi |
| Harmony Biosciences LLC | $396.65 | 2020-2025 | Wakix |
| Mylan Specialty L.P. | $271.08 | 2022-2024 | Yupelri |
| Takeda Pharmaceuticals U.S.A., INC. | $167.28 | 2023-2025 | Glassia |
| Viatris Specialty LLC | $124.17 | 2025 | Yupelri |
| Merck Sharp & Dohme LLC | $96.62 | 2019-2025 | Zerbaxa |
| Csl Behring | $94.72 | 2019-2023 | Kcentra |
| Medtronic, INC. | $65.80 | 2023-2024 | Stealthstation S8 Platform, Intellis Adaptivestim, Arcpoint |
| Janssen Pharmaceuticals, INC | $61.68 | 2019-2021 | |
| Baxter Healthcare | $57.75 | 2023-2024 | Hillrom - Monarch Airway Clearance System, Hillrom - Life 2000 Ventilation System |
| Regeneron Healthcare Solutions, INC. | $57.43 | 2022-2025 | Dupixent |
| Piramal Critical Care | $47.50 | 2019 | |
| Averitas Pharma INC. | $47.35 | 2024 | Qutenza |
| Merz Pharmaceuticals, LLC | $42.67 | 2024-2025 | Xeomin |
| Nevro Corp. | $41.10 | 2022-2024 | Senza |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $36.59 | 2025 | Inspire |
| Revance Therapeutics, INC. | $36.37 | 2024 | Daxxify |
| United Therapeutics Corporation | $34.51 | 2021-2024 | Tyvaso |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.81 | 2021 | |
| Mallinckrodt Enterprises LLC | $30.37 | 2019 | |
| Portola Pharmaceuticals, LLC | $20.42 | 2019 | |
| Tetraphase Pharmaceuticals, INC. | $20.20 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $19.95 | 2025 | Dysport |
| Pfizer INC. | $19.91 | 2024 | |
| Mallinckrodt Hospital Products INC. | $19.00 | 2020 | |
| Ani Pharmaceuticals, INC. | $18.91 | 2023 | Purified Cortrophin Gel |
| Si-Bone, INC. | $18.71 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.05 | 2025 | |
| Azurity Pharmaceuticals, INC. | $18.04 | 2023 | Gliadel |
| Providence Medical Technology, INC. | $17.98 | 2023 | |
| Jazz Pharmaceuticals INC. | $13.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devin Wells listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.